|
|
|
offer you
better services |
|
Tiotropium Bromide
Monohydrate |
|
|
|
We deliver the product Tiotropium Bromide
Monohdyrate to several customers in the chemical
and Pharmical industry.
Please note the Specification Data of
Tiotropium Bromide in the
following table. |
|
|
|
CERTIFICATE
OF ANALYSIS
|
PRODUCT
NAME: |
TIOTROPIUM
BROMIDE MONOHYDRATE |
BATCH
NUMBER: |
31001 |
|
BATCH
SIZE: |
250GM |
|
MAFG DATE: |
2003-10-2 |
|
EXP.DATE: |
2005-10-1 |
|
Analysis |
Standard |
Result |
Appearance |
White
crystalline powder |
Conforms |
Identification |
Most
absorb at 237 nm wavelength |
Conforms |
IR conform |
Conforms |
Related
substance,% |
1.5(max) |
Conforms |
PH |
4.5~6.5 |
5.2 |
Loss
in drying,% |
3.0~5.0 |
3.5 |
Heavy
metal |
20ppm |
Conforms |
Organic
Volatile |
200ppm(max) |
52ppm |
CH2CL |
|
|
Assay
(on dry basis) |
[C19H22BrNO4S2] |
|
98.5%(min) |
99.60% |
CONCLUSION:
IT CONFORMS TO THE STANDARD |
|
|
|
|
Applications |
|
|
|
|
|
|
|
Packing
&loading |
|
|
|
|
|
|
|
This data is only for your information purposes and does not imply
guarantee for a certain application.
|
|
|
|
If you need
an indicative price to your country, please kindly advise the annual
quantity needed, destination port and we will send you our soonest
CNF(Cost + Freight) price. Your indication for a workable price
level will sure speed up our fastest service for you |
|
|
|
We really need to get
feed back from our customers in order to improve our performances.
Any information about quotations from competitors will be welcomed
since we hope to work as a team with you.
Your kind help will be very much appreciated.
Best regards from SHENZHEN
, China
Mr. JEFFERY TSUI
|
|
|
|
|
|
|
|
Material
Safety Data Sheet |
|
|
|
|
|
|
|
Related Informations
and Materials |
|
|
|
Tiotropium
bromide (Ba 679 BR), a novel long-acting muscarinic antagonist for
the treatment of obstructive airways disease |
|
|
|
Spiriva®
Inhalation Powder:Tiotropium Bromide |
|
|
|
Treatment
of COPD Bronchodilator Muscarinic Antagonist:Tiotropium bromide |
|
|
|
|
|
|
|
|
|
|
|
If the above information
doesn't cover |
|
|
|
|
|